Compound Profile
Buspirone
Compound profile with evidence, safety, and practical fit.
Safety context — Current U. Details
- Evidence
- Limited evidence
- Typical onset
- Varies by prep
- Safety rating
- Safety context: Use caution
- Best for
- 5 HT1A Serotonergic Signaling, Anxiolytic Azapirone Activity
Safety
Safety & Cautions
Current U. S.
Elevated caution
Caution level: Elevated. One caution category applies — read it before use.
- Interaction-AwareMedication or interaction context is explicitly noted.
Evidence Summary
Profile-wide ·C LimitedEvidence lens
Read as directional context, not settled clinical proof.
Human clinical evidence: Present in source signals
Mechanistic / preclinical: Mechanism mapped
Research maturity: Emerging research — main contexts: 5 HT1A Serotonergic Signaling · Anxiolytic Azapirone Activity
Safety boundary: Safety note available — Current U.
Confidence estimate based on the design quality and consistency of published clinical trials.
Buspirone has a limited evidence rating.
Grade C: Limited Evidence
Evaluation of methodological rigor, population reach, and evidence alignment.
- Design Match
- Meta analysis
- Risk of Bias
- Low
- Consistency
- Not assessed
How evidence grades work
Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.
- Strong
- Multiple RCTs, consistent direction, adequate effect size
- Moderate
- Some RCTs or consistent observational data in humans
- Preliminary / Mixed
- Animal or in-vitro only, or conflicting human data
- Traditional / Theoretical
- Traditional use only; no controlled human trials
Clinical Study Summaries (4)2 human evidence sources · 0 human trials · Participant totals not consistently reported · Consistency not yet classifiable
Filter by study class
Showing 4 of 4 studies.
What the evidence actually shows
This table contains 4 structured sources, including 2 human evidence sources; 0 are human trials.
| Study | Design | N | Dose | Duration | Population | Outcome | Result & magnitude | Source |
|---|---|---|---|---|---|---|---|---|
Background | Meta-analysis Statistically combines results from multiple eligible studies; confidence still depends on the quality, consistency, and directness of those studies. | — | — | — | — | — | A 2023 systematic review and meta-analysis reported that azapirones as a class outperformed placebo for generalized anxiety disorder across 22 studies involving 2,567 participants, with evidence confidence varying by comparator. | PubMed → |
Background | Systematic review Uses a predefined method to find and evaluate relevant studies, but may or may not pool their results statistically. | — | — | — | — | — | A 2006 Cochrane review of 36 randomized trials involving 5,908 participants concluded that azapirones, including buspirone, were superior to placebo for generalized anxiety disorder, while comparative evidence against other treatments was less certain. | PubMed → |
Background | Other / unclear The study design is not yet classified clearly enough to infer its place in the evidence hierarchy. | — | — | — | — | — | A 12-month multicenter open-label study of 700 patients with generalized anxiety disorder reported symptom improvement and generally favorable tolerability during buspirone maintenance treatment. | PubMed → |
Background | Other / unclear The study design is not yet classified clearly enough to infer its place in the evidence hierarchy. | — | — | — | — | — | A 2026 U.S. DailyMed label indicates buspirone hydrochloride tablets for management of anxiety disorders or short-term relief of anxiety symptoms and states that controlled-trial effectiveness in long-term use beyond 3 to 4 weeks has not been demonstrated. | Source → |
Dosing
- No standardized dose
- No standardized dose is established for this ingredient in our source data. Preparations differ widely, so follow the standardization on the product you actually have and speak to a clinician before starting.
Botanical Context
Source botanicals and comparison guides related to Buspirone.
Compare & Sourcing
Compare side-by-side tradeoffs or verify active marker guidelines.
Review available sources for Buspirone
Independent database mapping — evaluated separately from safety and efficacy scores.
Affiliate disclosure: Shopping links may earn this site a commission at no cost to you. Links are chosen on quality and availability, never commission tiers; safety warnings and evidence ratings stay independent.
Safety first · Harm reduction
This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.
Learn how we evaluate confidence, safety, and intensity on the methodology page.
Founder & Head Researcher · Oak Ridge, TN · Last reviewed August 2026
Editorial Review
Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.
Help improve this profile
Was this useful for your research?
These controls record only the page and the structured choice you make when analytics consent is enabled. Please don’t include personal medical information in research requests.
Was this evidence summary clear?
Did you find what you were researching?
Free safety checklist
Get the Buspirone evidence notes
Occasional research updates, safety context, and product-quality checks for supplement decisions.
We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.